Hi GMT2!
Yes - more good news. Expected - but still good to hear.
I also find it interesting that IMU mentions Gilead's Yescarta. They used similar wording back in October. Gilead has been pushing hard in the CAR-T space and sees it as the future. They paid a shirt load to buy Kite Pharma, who developed Yescarta. $11.9b USD, I believe.
You would have to think that Gilead has been watching OnCARlytics with considerable interest. For that matter - also Azer-Cel.
Cheers
Dave
Hi GMT2!Yes - more good news. Expected - but still good to...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.6¢ |
Change
-0.001(1.30%) |
Mkt cap ! $556.3M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 7.9¢ | 7.5¢ | $2.780M | 36.36M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 108996 | 7.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.7¢ | 254900 | 3 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.6¢ |
Change
-0.001 ( 1.17 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.5¢ | 17617693 | ||
| Last updated 15.59pm 07/05/2024 ? | |||||
| IMU (ASX) Chart |